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Abstract
Pre-pregnancy maternal obesity is associated with adverse offspring outcomes at birth and later in life. Individual studies
have shown that epigenetic modifications such as DNA methylation could contribute. Within the Pregnancy and Childhood
Epigenetics (PACE) Consortium, we meta-analysed the association between pre-pregnancy maternal BMI and methylation at
over 450,000 sites in newborn blood DNA, across 19 cohorts (9,340 mother-newborn pairs). We attempted to infer causality by
comparing the effects of maternal versus paternal BMI and incorporating genetic variation. In four additional cohorts (1,817
mother-child pairs), we meta-analysed the association between maternal BMI at the start of pregnancy and blood methyla-
tion in adolescents. In newborns, maternal BMI was associated with small (<0.2% per BMI unit (1 kg/m2), P<1.06107) meth-
ylation variation at 9,044 sites throughout the genome. Adjustment for estimated cell proportions greatly attenuated the
number of significant CpGs to 104, including 86 sites common to the unadjusted model. At 72/86 sites, the direction of the
association was the same in newborns and adolescents, suggesting persistence of signals. However, we found evidence for
a6causal intrauterine effect of maternal BMI on newborn methylation at just 8/86 sites. In conclusion, this well-powered anal-
ysis identified robust associations between maternal adiposity and variations in newborn blood DNA methylation, but
these small effects may be better explained by genetic or lifestyle factors than a causal intrauterine mechanism. This high-
lights the need for large-scale collaborative approaches and the application of causal inference techniques in epigenetic
epidemiology.
Introduction
Offspring of mothers with a high body mass index (BMI) at the
start of pregnancy have a higher risk of obesity and obesity-
related disorders in later life (1). Maternal obesity in pregnancy
is also associated with other offspring outcomes, including
neurodevelopmental and respiratory outcomes (2–5). These
associations might be explained by shared mother-child genetic
or postnatal environmental influences, or they could also reflect
a causal intrauterine mechanism leading to early programming
of adverse health in the offspring (6).
4069Human Molecular Genetics, 2017, Vol. 26, No. 20 |
Disentangling the genetic and shared postnatal environmen-
tal effects from a causal intrauterine effect is difficult, but there
are a number of causal inference approaches that may be useful
(7). For example, some studies have used a negative control
design whereby the association between maternal adiposity and
offspring outcome is compared to the association between pater-
nal adiposity and the same outcome. The key assumption of the
negative control design is that both exposures share the same
postnatal environmental and genetic confounders. A systematic
review (8) of such studies, together with subsequent studies not
included in the review (9–12), have found only limited support for
specific effects of maternal adiposity on offspring adiposity
beyond birth. To our knowledge, similar causal inference techni-
ques have not yet been applied to study maternal effects of
adiposity in pregnancy on other aspects of offspring health.
If there is a causal intrauterine effect of maternal adiposity
on offspring health outcomes, the mechanism is unclear.
Epigenetic modifications, such as DNA methylation, might
partly mediate associations between maternal and offspring
phenotypes by causing changes to gene expression that are
mitotically heritable (6,13–15). Differential DNA methylation has
been reported when assessing offspring exposed in utero to
extreme maternal undernutrition (16–19), maternal morbid obe-
sity (20) and less extreme maternal underweight and maternal
obesity (21), in comparison to those not exposed; yet weak or no
evidence has been found for associations between continuous
maternal BMI and offspring DNA methylation, whether globally
(22,23), at specific loci identified in array (21,24,25) or at candi-
date genes (26). However, individual studies were limited in
sample size and thus underpowered to detect differential meth-
ylation. Meta-analysis of results from multiple individual
cohorts increases sample size and power to detect differential
methylation, but this approach has rarely been employed in the
field of epigenetic epidemiology.
Comprising many birth cohorts from around the world, the
Pregnancy and Childhood Epigenetics (PACE) Consortium25 was
established to facilitate meta-analysis of epigenome-wide stud-
ies relevant to maternal and childhood health and disease. In
this PACE study, we meta-analysed harmonised cohort-specific
epigenome-wide data on associations between maternal BMI at
the start of pregnancy and DNA methylation in the blood of
newborns. We then conducted further analyses (Fig. 1) to
explore whether these associations could be reproduced in ado-
lescent samples, and implemented causal inference methods to
evaluate the potential confounding effects of shared environ-
ment and genetic variation.
Results
Study characteristics
We meta-analysed results from 19 independent cohorts to test
the association between maternal BMI at the start of pregnancy
and epigenome-wide newborn blood DNA methylation. A
summary of methods used by each cohort is provided in
Supplementary Material, Table S1, with a more detailed descrip-
tion in the Supplementary Methods. Supplementary Material
Table S2 lists sample sizes and summarises EWAS results for
each cohort and meta-analysis. For our primary model, with
continuous maternal BMI as the exposure, we analysed results
from 7,523 mother-child pairs. The overall sample size-
weighted mean maternal BMI was 24.4 kg/m2 (range of cohort-
specific means: 22.8, 27.8). In secondary analyses, we examined
World Health Organisation categories for maternal BMI, com-
paring normal weight women (n¼ 4,834) to i) overweight or
obese women combined (n¼ 2,885 women, of whom 1,299 were
obese) and ii) underweight women (n¼ 211 women). The major-
ity of participants were of European ancestry. Table 1 summa-
rizes the characteristics of each cohort.
Maternal BMI at the start of pregnancy is associated
with widespread but small differences in newborn blood
DNAmethylation
When treated as a continuous variable, maternal BMI at the
start of pregnancy was associated with differential methylation
Figure 1. An overview of the study design.
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in newborn blood at 9,044 sites (Supplementary Material, Table
S3) before and 104 sites (Supplementary Material, Table S4) after
adjustment for cell-counts (Bonferroni correction for 473,864
tests P< 1.06107); 86 sites were common to both models.
Before adjustment for cell-counts, lambdas (k), a measure of P-
value inflation, were generally high and QQ plots showed infla-
tion of P-values in most cohorts (Table 2, Supplementary
Material, Table S2 and Supplementary Figures pages 2–5).
Values for k were closer to 1 for most cohorts after adjustment
for estimated cell counts. In a meta-analysis of results from two
of the larger cohorts, ALSPAC and Generation R (k¼ 1.60), k was
not substantially further reduced after removal of potential out-
liers using the Tukey method (27) (k¼ 1.58) or additional adjust-
ment for 10 ancestry principal components (k¼ 1.67).
Sites associated with maternal BMI were spread over the
genome and did not tend to be restricted to certain regions (Fig.
2). Effect sizes were very small, with the median absolute effect
at the genome-wide significant sites being a difference in meth-
ylation beta value of 0.0003 per one unit (kg/m2) increase in
maternal BMI (i.e. a 0.03% absolute change, range: 0.15%
decrease to 0.13% increase). At most of the Bonferroni-
significant sites (8,899/9,044 and 96/104), higher maternal BMI
was associated with lower newborn blood methylation.
Results from the primary model, where the exposure was
continuous BMI, were consistent with those from a binary com-
parison of maternal overweight/obesity (BMI> 25) with normal
weight (BMI 18.5 to 25): the Spearman’s coefficient for correla-
tion between regression coefficients was 0.70. Maternal over-
weight/obesity was associated with differential newborn blood
methylation at 4,037 sites (Supplementary Material, Table S5)
before and 159 sites (Supplementary Material, Table S6) after
cell-adjustment (P< 1.06107), compared with normal weight.
The crossover between these 159 sites and the 104 identified
with P< 1.06107 in the cell-adjusted continuous model was
just 21/104, but 150/159 were associated with continuous BMI
after correction for multiple testing at 159 sites (FDR-corrected
P< 0.05). The direction of effect for the binary comparison was
consistent with that for the continuous exposure at all 159 sites.
As expected, the magnitude of effect was larger when BMI was
binary than when BMI was continuous, but the median effect at
sites with P< 1.06107 was still small (0.31% decrease in mean
methylation beta value in the overweight/obese group com-
pared to the normal weight group).
Eight sites (Supplementary Material, Table S7) were associ-
ated with maternal underweight (BMI< 18.5) compared to nor-
mal weight with P< 1.06107, but this analysis was likely
underpowered given the small number of underweight women
(n¼ 211), and there was large inter-study heterogeneity in
results (I2 median 62.3, range 0 to 91.3). Given these results, we
did not explore the association between maternal underweight
and offspring methylation any further.
Adjusting for cellular heterogeneity greatly attenuates
associations between maternal BMI and newborn blood
DNAmethylation
As mentioned above, adjusting for estimated cell proportions in
newborn blood samples greatly reduced the number of sites
associated with maternal BMI with P-values< 1.06107 (Fig. 3).
This reduction in signal was seen in all meta-analyses and most
individual cohort analyses (Table 2). At all 9,044 sites associated
with continuous maternal BMI, adjusting for cell counts shifted
the effect size towards the null. The median relative change in
estimate after adjustment was 52% and 9,007/9,044 sites attenu-
ated by 10% or more. After adjustment, the precision of the
Table 1. Characteristics of each cohort included in the meta-analysis of the association between maternal pre-pregnancy BMI and offspring
blood DNA methylation at birth. BMI is categorised according to WHO guidelines
Cohort N in
continuous
Mean maternal
BMI (SD)
Mean maternal
age (SD)
Total Total Total Total Ethnicity
BMI model in continuous
BMI model
in continuous
BMI model
N
obese
N over
weight
N under
weight
N normal
weight
ALSPAC 788 22.8 (3.6) 29.7 (4.4) 37 106 26 619 European
CBC (Hispanic) 132 24.2 (5.7) 27.2 (5.7) 15 27 11 79 Hispanic
CBC (White) 155 23.3 (3.9) 32.0 (5.7) 8 34 0a 108 European
CHAMACOS 368 26.9 (5.1) 25.3 (5.0) 80 141 3a 144 Hispanic
EARLI 211 27.8 (6.9) 34.0 (4.7) 69 51 3a 88 European/Mixed
GECKO 176 24.2 (3.9) 30.4 (4.0) 14 45 3a 114 European
GEN3G 170 24.8 (5.6) 28.0 (4.1) 25 33 3a 109 European
Generation R 875 24.5 (4.2) 31.5 (4.2) 90 202 13a 570 European
GOYAb 545 23.1 (3.2) 29.5 (4.1) 466 106 16 387 European
IOW F2 53 27.7 (7.3) 21.5 (1.4) 19a 11a 0a 23 European
MEDALL (INMAþEDEN) 330 24.1 (5.1) 30.6 (4.5) 37 62 26 205 European
MoBa1 1034 24.0 (4.6) 29.9 (4.3) 98 215 67 688 European
MoBa2 647 24.2 (4.4) 30.0 (4.5) 72 136 18 431 European
MoBa3 231 24.2 (4.3) 29.6 (4.4) 25 49 5a 152 European
NEST 384 27.6 (8.9) 28.8 (6.4) 108 76 19a 181 Mixed
NFCS 867 23.5 (4.1) 29.1 (4.9) 70 157 37 603 European
NHBCS 118 24.4 (4.2) 31.0 (4.4) 12 29 3a 74 European
RICHS 96 25.8 (6.9) 28.3 (5.5) 21 21 10 44 European
Project Viva 343 24.3 (4.9) 33.1 (4.5) 41 77 10a 215 European
Meta-analysis 7523
aIncluded in the continuous BMI model, but excluded from the categorical analyses due to low sample sizes.
bA subset of the GOYA cohort (545) was included in the continuous BMI model. The entire cohort (975) was included in the binary BMI models.
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estimates at 8,984/9,044 sites was increased (i.e. the standard
error was reduced). Taken together, this suggests that much of
the association between maternal BMI at the start of pregnancy
and newborn DNA methylation is due to varying cell type
proportions.
Surprisingly, however, estimated cell proportions were not
strongly correlated with maternal BMI in any of the five cohorts
that supplied these data (Supplementary Material, Table S8).
Given this, we hypothesised that large changes in estimates
might indicate measurement error in estimated cell counts, and
that this measurement error might be due to an adult whole
blood reference panel being used to estimate cell counts in
cord/newborn blood samples. However, we found little evidence
for this: cord blood reference panels by Andrews and Bakulski
(28), Gervin et al. (29) and deGoede et al. (30) became available
after we had finalised the meta-analysis results. When we used
each of these references to estimate cell proportions in ALSPAC
cord blood samples, regression coefficients and P-values were
similar to those obtained when an adult reference panel was
used in this cohort. Of the 86 sites where maternal BMI was
associated with newborn methylation before and after adjust-
ment for cell counts in the meta-analysis (P< 1.06107), 15
were associated with maternal BMI with P< 0.05 in ALSPAC
when an adult reference panel was used. Of these 15 sites, 12
sites also had P< 0.05 when any of the cord blood reference pan-
els were used. The percentage change in estimates between
models using the adult and cord blood reference panels was
under 10% at 14/15 sites using the Andrews and Bakulski refer-
ence (median percentage change in estimates: 4.1), under 10%
at 14/15 sites using the Gervin et al. reference (median percent-
age change in estimates: 3.4) and under 10% at 12/15 using the
deGoede reference (median percentage change in estimates:
3.7). Furthermore, cell counts estimated using any of the three
cord blood references correlated relatively well with each other
(median Spearman’s correlation coefficient: 0.67, range: 0.05 to
0.95), but were not correlated with maternal BMI (median
Spearman’s correlation coefficient: 0.007, range: 0.10 to 0.15)
(Supplementary Material, Table S8). Although maternal BMI was
not associated with estimated cell proportions in our data,
others have observed that maternal BMI is associated with cord
blood cellular heterogeneity (31,32), in addition, some random
variability in cell distribution across the range of maternal BMI
can be expected. Therefore, we believe that adjustment is
appropriate and indeed necessary.
Further analysis of 86 sites where maternal BMI is
associated with newborn DNAmethylation both before
and after adjustment for cell counts
For further analysis, we selected the 86 sites where maternal
BMI at the start of pregnancy was associated with offspring
newborn blood DNA methylation both before and after adjust-
ment for estimated cell proportions (Table 3), and performed
subsequent analyses using the cell-adjusted model. We used
three main strategies to determine the robustness of our find-
ings at these 86 sites:
Firstly, we assessed inter-study heterogeneity and influence
of individual studies. There was weak to moderate heterogene-
ity at most sites; I2 was less than 40% at 57/86 sites (median
31.2%, range 0.0 to 70.6%) and 31/86 sites had a heterogeneity
P-value<0.05. In a comparison of estimates from random- and
fixed-effects meta-analysis models, the percentage change in
estimates was<10% for 72/86 sites (median percentage change
in estimates: 2.8). In the random effects model, the largest
P-value at the 86 sites was 0.0058 and 20/86 sites had
P< 1.06107, despite lower power compared to the fixed effects
model. Forest plots and results of a leave-one-out analysis
showed that results from most cohorts agreed on the direction
of effect at the 86 top sites and no single cohort consistently
had a disproportionately large influence on the meta-analysis
(Supplementary Figures, pages 6–37).
Table 2. Summary of cohort-specific and meta-analysis results for EWAS of continuous maternal pre-pregnancy BMI and newborn blood DNA
methylation
Cohort N Lambda (before
adjusting for cells)
Bonferroni hits (before
adjusting for cells)
Lambda (after
adjusting for cells)
Bonferroni hits
(after adjusting for cells)
ALSPAC 788 1.53 12 1.18 1
CBC (Hispanic) 132 1.05 12 0.96 7
CBC2 (White) 155 1.80 31 1.19 3
CHAMACOS 368 1.34 1 0.87 0
EARLI 211 0.88 0 0.89 2
GECKO 176 1.75 14 1.15 2
GEN3G 170 1.13 10 1.04 10
GENR 875 1.86 248 1.96 11
GOYA 545 1.87 2 1.01 1
IOW F2 53 1.08 0 1.05 0
MEDALL (INMAþEDEN) 330 1.24 0 0.92 0
MoBa1 1034 4.69 39 2.74 1
MoBa2 647 2.70 8 2.76 14
MoBa3 231 1.03 0 0.78 1
NEST 384 0.76 0 0.93 0
NFCS 867 0.95 0 0.98 0
NHBCS 118 1.02 2 1.17 4
RICHS 96 1.89 14 2.92 33
VIVA 343 1.27 8 1.49 7
FE Meta-analysis 7523 3.27 9044 2.41 104
RE Meta-analysis 1825 25
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Secondly, we performed a sensitivity analysis restricting the
meta-analysis to 15/19 cohorts comprising participants of
European origin only. The results from this sensitivity analysis
were consistent with those of the main analysis. The
Spearman’s correlation coefficient for regression coefficients
was 0.91, and the percentage change in estimates was>10% for
47/86 sites (median percentage change in estimates: 9.7%).
While this modest difference could reflect confounding by
ancestry, it might also occur because the cohorts of non-
European ancestry tended to have a higher mean maternal BMI
and were more variable compared to the European ancestry
cohorts (Table 1).
Thirdly, we compared the 86 sites to a list of 190,672 probes
on the Illumina 450k platform that Naeem et al. (33) suggested
might give spurious readings (Supplementary Material, Table
S9). Forty-two sites were on this list: seven located in regions
containing SNPs, 11 in regions containing repeat sequences and
four in regions where insertions or deletions are found. These
Figure 2. A Manhattan plot for the meta-analysis of associations between maternal pre-pregnancy BMI and offspring DNA methylation at birth after adjustment
for maternal covariates and estimated cell counts. The red line shows the Bonferroni threshold for multiple testing. Methylation sites that surpassed the Bonferroni-
correction threshold (P<1.06107) before and after adjustment for estimated cell counts are highlighted in blue.
Figure 3. Volcano plots to illustrate the large increase in P-values after adjusting for estimated cell counts. Methylation sites that reached the Bonferroni threshold for
multiple testing (1.06107) are highlighted in blue.
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Table 3. Methylation sites where continuous maternal pre-pregnancy BMI was associated with offspring newborn blood methylation with a
Bonferroni-corrected P-value<0.05 (P< 1.06 107) before and after adjustment for cell counts
Cell-unadjusted model Cell-adjusted model
CHR CpG site Gene ba SE P ba SE P
7 cg12009398 VIPR2 1.31E-03 1.42E-04 2.49E-20 1.01E-03 1.34E-04 5.88E-14
13 cg09285795 SOX1 7.75E-04 1.10E-04 2.09E-12 7.71E-04 1.12E-04 5.99E-12
2 cg23080818 RBMS1 8.76E-04 1.08E-04 4.76E-16 6.98E-04 1.04E-04 1.96E-11
12 cg25213362 TMPRSS12 6.71E-04 8.91E-05 4.93E-14 5.89E-04 8.82E-05 2.42E-11
10 cg17782974 TRIM8 1.29E-03 1.50E-04 7.18E-18 8.15E-04 1.25E-04 6.54E-11
7 cg05086444 VIPR2 8.32E-04 1.30E-04 1.79E-10 8.17E-04 1.25E-04 7.14E-11
1 cg03258665 EPHA2 1.10E-03 1.12E-04 8.65E-23 5.68E-04 8.78E-05 9.97E-11
12 cg20065216 DUSP16 6.63E-04 9.88E-05 1.97E-11 6.03E-04 9.32E-05 9.98E-11
11 cg26434090 DSCAML1 7.94E-04 1.07E-04 1.10E-13 6.97E-04 1.10E-04 2.27E-10
11 cg18268562 FOXR1 6.27E-04 1.01E-04 4.72E-10 6.51E-04 1.03E-04 2.36E-10
8 cg00285394 SQLE 8.68E-04 1.39E-04 4.57E-10 8.96E-04 1.42E-04 2.66E-10
22 cg27179375 POM121L1P 1.33E-03 2.00E-04 2.85E-11 1.07E-03 1.71E-04 3.65E-10
6 cg05586134 PTCRA 4.81E-04 6.32E-05 2.80E-14 3.32E-04 5.33E-05 4.54E-10
3 cg07357021 PRICKLE2 3.94E-04 5.08E-05 9.48E-15 2.82E-04 4.59E-05 7.68E-10
1 cg21778193 MIR200B 1.09E-03 1.48E-04 1.42E-13 8.75E-04 1.42E-04 7.86E-10
8 cg04836151 LY6H 9.72E-04 1.37E-04 1.27E-12 7.03E-04 1.15E-04 9.77E-10
17 cg09243648 SP6 9.32E-04 1.25E-04 8.14E-14 6.00E-04 9.85E-05 1.13E-09
15 cg07822775 PCSK6 5.55E-04 6.98E-05 1.86E-15 3.44E-04 5.65E-05 1.18E-09
10 cg14906690 KAT6B 8.09E-04 1.07E-04 3.76E-14 7.06E-04 1.17E-04 1.47E-09
2 cg05309280 GORASP2 5.62E-04 1.01E-04 2.63E-08 6.07E-04 1.01E-04 1.58E-09
4 cg10635092 ZFYVE28 7.89E-04 1.27E-04 5.12E-10 7.11E-04 1.19E-04 2.30E-09
20 cg13403462 NECAB3 1.37E-03 2.23E-04 9.21E-10 1.38E-03 2.30E-04 2.36E-09
17 cg10187674 ABCA5 2.98E-04 5.39E-05 3.05E-08 3.21E-04 5.39E-05 2.47E-09
3 cg19762797 XXYLT1 3.38E-04 4.32E-05 5.28E-15 2.13E-04 3.58E-05 2.92E-09
1 cg09230763 MAP3K6 9.16E-04 1.10E-04 8.18E-17 6.04E-04 1.02E-04 3.09E-09
19 cg18156417 MAP2K2 3.49E-04 5.11E-05 8.01E-12 2.82E-04 4.77E-05 3.51E-09
7 cg26220185 MAD1L1 6.65E-04 9.48E-05 2.23E-12 4.06E-04 6.88E-05 3.68E-09
17 cg13540311 SEPT9 3.33E-04 4.70E-05 1.40E-12 2.46E-04 4.17E-05 3.92E-09
2 cg16877087 RBMS1 5.85E-04 9.39E-05 4.72E-10 5.62E-04 9.59E-05 4.66E-09
1 cg20594982 AGRN 1.20E-03 1.70E-04 1.57E-12 9.95E-04 1.70E-04 5.17E-09
8 cg14660676 SQLE 1.09E-03 1.72E-04 2.36E-10 1.05E-03 1.80E-04 5.21E-09
9 cg09723488 LHX6 5.87E-04 7.14E-05 2.06E-16 3.41E-04 5.84E-05 5.38E-09
8 cg13176454 ST3GAL1 2.98E-04 3.77E-05 2.92E-15 2.00E-04 3.43E-05 5.49E-09
8 cg14030674 ANK1 1.08E-03 1.32E-04 3.01E-16 5.50E-04 9.46E-05 5.97E-09
10 cg27102629 KAT6B 9.89E-04 1.24E-04 1.90E-15 6.68E-04 1.16E-04 7.37E-09
2 cg06399427 RBMS1 5.17E-04 8.11E-05 1.88E-10 4.76E-04 8.23E-05 7.39E-09
16 cg01979489 PDIA2 4.74E-04 6.71E-05 1.57E-12 3.24E-04 5.63E-05 8.54E-09
7 cg05837990 CDHR3 1.44E-03 2.39E-04 1.83E-09 1.40E-03 2.43E-04 9.12E-09
9 cg21241902 NSMF 6.10E-04 8.93E-05 8.16E-12 4.87E-04 8.49E-05 9.88E-09
8 cg00729699 DMTN 7.83E-04 1.15E-04 1.16E-11 5.52E-04 9.64E-05 1.03E-08
20 cg03719642 UCKL1 6.86E-04 1.18E-04 5.46E-09 6.83E-04 1.19E-04 1.07E-08
8 cg18144647 SFRP1 5.55E-04 9.28E-05 2.14E-09 5.22E-04 9.13E-05 1.11E-08
12 cg21814615 KNTC1 4.62E-04 7.19E-05 1.34E-10 3.64E-04 6.41E-05 1.43E-08
1 cg14528056 GBAP1 6.87E-04 1.14E-04 1.75E-09 5.14E-04 9.08E-05 1.45E-08
1 cg22820188 LMNA 7.08E-04 8.59E-05 1.69E-16 4.38E-04 7.74E-05 1.56E-08
14 cg08289937 DDHD1 3.54E-04 4.74E-05 7.43E-14 2.51E-04 4.44E-05 1.56E-08
9 cg21186778 RCL1 7.09E-04 9.24E-05 1.67E-14 3.63E-04 6.43E-05 1.58E-08
5 cg17514558 PCDHB19P 6.14E-04 1.09E-04 1.69E-08 6.46E-04 1.14E-04 1.67E-08
8 cg15240102 LOC286083 7.30E-04 9.23E-05 2.74E-15 4.00E-04 7.10E-05 1.80E-08
18 cg21026022 CABYR 1.21E-03 1.75E-04 5.52E-12 9.95E-04 1.77E-04 1.87E-08
13 cg18995031 RASA3 4.11E-04 5.70E-05 5.85E-13 2.84E-04 5.09E-05 2.31E-08
22 cg04027757 POM121L1P 7.26E-04 1.27E-04 9.59E-09 6.45E-04 1.15E-04 2.33E-08
6 cg01963618 LINC01622 4.79E-04 6.77E-05 1.39E-12 3.51E-04 6.29E-05 2.40E-08
20 cg21445553 GGTLC1 1.09E-03 1.87E-04 5.90E-09 9.50E-04 1.70E-04 2.41E-08
16 cg05976575 CMTM2 4.72E-04 6.35E-05 1.15E-13 3.21E-04 5.75E-05 2.49E-08
2 cg13758186 CREG2 4.86E-04 7.71E-05 2.90E-10 3.89E-04 6.98E-05 2.52E-08
2 cg20710902 BUB1 3.44E-04 5.63E-05 1.04E-09 2.74E-04 4.94E-05 2.88E-08
6 cg03046925 GPX6 4.25E-04 6.26E-05 1.06E-11 2.80E-04 5.05E-05 2.98E-08
10 cg18330571 EBF3 4.92E-04 7.14E-05 5.75E-12 3.68E-04 6.65E-05 3.15E-08
(continued)
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sites may be more likely to contain outlier values that influence
results, however diptests for multimodality (34) and visual
inspection of density plots of methylation beta values in
ALSPAC and GOYA did not support this (P> 0.05;
Supplementary Figures, pages 38–51). Additionally, all cohort-
specific analyses were conducted using robust linear regression,
which is designed to be robust to outliers in the outcome varia-
ble (methylation). Other reasons that probes had been flagged
by Naeem et al. as potentially problematic were that they
hybridise to multiple genomic loci (four sites), did not produce
results consistent with those produced by whole-genome bisul-
fite sequencing (nine sites) and were particularly susceptible to
errors in bisulfite conversion (four sites).
Maternal BMI-associated newborn blood methylation
sites are not enriched for certain biological processes or
pathways
Maternal BMI-associated newborn blood methylation sites
were spread throughout the genome and did not appear to
cluster in certain chromosomal regions. The 86 maternal BMI-
associated methylation sites are near 77 gene regions, and
there were several instances where multiple sites mapped to
the same gene: RBMS1 [3 sites], POM121L1P [3 sites], VIPR2 [2
sites], SQLE [2 sites], RASA3 [2 sites], MIR200B [2 sites], KAT6B [2
sites]. The list of 77 genes was not enriched for any gene ontol-
ogy (GO) term (Supplementary Material, Table S10) or KEGG
pathway (Supplementary Material, Table S11) after FDR-
correction for multiple testing, but this analysis was likely
underpowered.
Associations between maternal BMI at the start of
pregnancy and newborn DNAmethylation were
reproduced in the whole blood of adolescents at most
sites
In order to assess whether associations at birth are also present
in later childhood, four cohorts (BAMSE, IOW birth cohort [IOW
F1], PIAMA, and RAINE; total n¼ 1,817 mother-child pairs) con-
tributed results to a meta-analysis of maternal BMI at the start
of pregnancy and methylation in the whole blood of adolescent
offspring (age range: 15 to 18 years, weighted mean: 17 years).
Cohorts are summarised in Table 4. These cohorts were com-
pletely independent of those that contributed results to the
newborn analysis, therefore we were able to assess reproduci-
bility of our newborn results later in life. All models discussed
here were corrected for estimated cell counts. Full results are
provided in Supplementary Material, Table S12.
There was evidence for reproducible associations at most of
the 86 sites: the direction of association at adolescence was the
same as that at birth for 72/86 sites (Spearman correlation coeffi-
cient: 0.67). Twenty-two of these 72 sites had a P-value<0.05 at
adolescence, despite the much smaller sample size. Although no
associations survived correction for multiple testing at 86 sites,
22/72 sites with nominal P-values<0.05 is higher than the 5%
expected by chance alone (Kolmogorov P¼ 3.31016). Across the
72 sites where effects were in the same direction, the effect esti-
mates in the adolescence analysis were a median of 2.25 times
smaller (i.e. closer to the null) than the effect estimates in the
newborn analysis (range: 2889 times smaller to 1.35 times larger)
but at some sites, estimates at both time points were remarkably
similar (Fig. 4). It is also of particular note that six of the top ten
Table 3. (continued)
Cell-unadjusted model Cell-adjusted model
CHR CpG site Gene ba SE P ba SE P
3 cg11156132 PRKCD 6.83E-04 9.30E-05 1.97E-13 3.21E-04 5.82E-05 3.36E-08
2 cg18499001 LOC388942 2.04E-04 3.75E-05 4.98E-08 2.12E-04 3.85E-05 3.72E-08
2 cg05113927 UCN 6.23E-04 1.11E-04 1.83E-08 6.10E-04 1.11E-04 3.85E-08
4 cg22670329 CXCL6 4.29E-04 7.97E-05 7.32E-08 4.16E-04 7.56E-05 3.86E-08
2 cg15913725 TSSC1 2.76E-04 4.46E-05 5.89E-10 2.37E-04 4.32E-05 4.46E-08
7 cg01881287 EFCAB10 8.12E-04 1.29E-04 3.40E-10 7.22E-04 1.32E-04 4.84E-08
16 cg05635274 PRSS21 5.84E-04 9.30E-05 3.24E-10 4.82E-04 8.84E-05 4.95E-08
16 cg03221837 IRX3 5.48E-04 7.77E-05 1.73E-12 4.22E-04 7.76E-05 5.20E-08
13 cg13557773 RASA3 9.98E-04 1.74E-04 9.82E-09 9.53E-04 1.75E-04 5.42E-08
8 cg14434213 RNF5P1 8.52E-04 1.42E-04 2.21E-09 7.83E-04 1.45E-04 6.04E-08
6 cg05659486 LRRC1 6.47E-04 8.98E-05 5.82E-13 4.10E-04 7.58E-05 6.22E-08
5 cg15029475 C5orf38 7.23E-04 1.01E-04 7.55E-13 4.88E-04 9.01E-05 6.32E-08
19 cg22545168 LAIR1 4.79E-04 6.92E-05 4.62E-12 3.49E-04 6.45E-05 6.32E-08
5 cg23111106 OSMR 4.73E-04 6.81E-05 3.77E-12 3.16E-04 5.85E-05 6.34E-08
7 cg23749005 PTPRN2 1.00E-03 1.66E-04 1.36E-09 8.95E-04 1.65E-04 6.34E-08
17 cg21937867 PRCD 4.63E-04 6.56E-05 1.70E-12 2.88E-04 5.33E-05 6.39E-08
1 cg04972348 MIR200B 1.30E-03 1.65E-04 3.23E-15 8.61E-04 1.59E-04 6.66E-08
14 cg05881436 SNAPC1 3.59E-04 5.77E-05 4.93E-10 2.78E-04 5.16E-05 6.84E-08
3 cg23166970 MCCC1 1.32E-04 2.42E-05 4.87E-08 1.29E-04 2.39E-05 7.66E-08
5 cg08407524 LINC01023 3.49E-04 5.16E-05 1.27E-11 2.33E-04 4.34E-05 8.28E-08
14 cg01428678 GPHN 1.89E-04 3.38E-05 2.19E-08 1.85E-04 3.45E-05 8.69E-08
19 cg26284544 TGFBR3L 8.41E-04 1.44E-04 5.39E-09 7.64E-04 1.43E-04 8.79E-08
3 cg12155036 LINC00887 6.84E-04 1.22E-04 2.04E-08 6.49E-04 1.21E-04 9.00E-08
22 cg25432807 POM121L1P 6.07E-04 1.10E-04 3.08E-08 5.35E-04 1.00E-04 9.32E-08
6 cg25521481 TTBK1 7.08E-04 1.01E-04 2.53E-12 5.34E-04 1.00E-04 9.78E-08
3 cg25185429 ITPR1 3.02E-04 3.96E-05 2.44E-14 1.79E-04 3.37E-05 1.02E-07
2 cg01517690 ZSWIM2 6.24E-04 1.08E-04 7.55E-09 5.52E-04 1.04E-04 1.02E-07
aDifference in newborn DNA methylation beta value per 1 kg/m2 increase in maternal pre-pregnancy BMI.
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sites with the largest effect size were the same at birth and ado-
lescence. These sites were cg05837990 (CDHR3), cg13403462
(ACTL10/NECAB3), cg27179375 (POM121L1P), cg12009398 (VIPR2),
cg20594982 (AGRN) and cg21445553 (GGTLC1). One of the top ten
sites with the smallest P-values was also common to both analy-
ses: cg05086444 (VIPR2).
Negative control design supports a causal intrauterine
effect of maternal BMI on newborn blood methylation at
nine sites
We used a negative control design (7) in an attempt to disen-
tangle a potential causal, intrauterine effect of maternal BMI
on newborn blood methylation from the effect of confounding
by shared genetics or postnatal environment. The logic is that
paternal and maternal exposures may both be associated with
offspring methylation due to shared familial confounding fac-
tors or by inheritance of parental genotypes, but paternal BMI
would not normally be expected to affect the intrauterine
environment. Therefore, if there is a causal intrauterine
influence, only maternal BMI would be expected to be
independently associated with methylation. Evidence for an
intrauterine effect is stronger where estimates for associations
between maternal BMI and offspring DNA methylation are
greater than the equivalent estimates for paternal BMI.,
whereas consistent maternal and paternal estimates provides
evidence for confounding by genetic or shared postnatal envi-
ronmental factors.
It is also important to adjust the maternal estimate for pater-
nal BMI, and vice versa, because maternal and paternal BMI are
somewhat correlated due to assortative mating. For example, in
the cohorts that contributed to this study, Spearman’s correla-
tion coefficients between maternal and paternal BMI ranged
from 0.18 to 0.25 (P< 0.001).
Seven cohorts contributed results to this negative control
analysis: ALSPAC (n¼ 619), CHAMACOS (n¼ 180), Generation R
(n¼ 829), GOYA (n¼ 422), MEDALL (INMA and EDEN pooled
n¼ 316), NHBCS (n¼ 96) and RICHS (n¼ 92). The total number of
families included in the meta-analysis of the mutually adjusted
models was 2,554. Results for all models are provided in
Supplementary Material, Table S13.
Based on the above criteria, we found some evidence for a
causal intrauterine effect of maternal BMI on newborn blood
methylation at some sites: At 64 of 86 sites, the paternal and
maternal effect estimates were in the same direction, i.e. we could
be more certain that no independent paternal-specific effect exists.
At 40 of these 64 sites, the maternal BMI estimate was greater than
the paternal BMI estimate after mutual adjustment (median 2.19
times greater, range 1.01 to 142.4 times greater). At nine of these 40
sites, there was some evidence of heterogeneity between the
mutually adjusted maternal and paternal BMI estimates (I2>40;
Supplementary Material, Table S14). These criteria were used to
define support for a possible maternal specific, intrauterine effect.
Therefore, at 77/86 sites, evidence from this negative control study
was more supportive of the association between maternal BMI and
newborn blood methylation being explained by genetic or shared
prenatal environmental factors than a causal intrauterine effect.
Figure 5 displays the results for the 20 sites where the mutually
adjusted maternal and paternal BMI estimates were in the same
direction, with the maternal effect being larger than the paternal
effect and having a P-value<0.05 (Fig. 5).
meQTLs at maternal BMI-associated cord blood
methylation sites provide further support for
confounding by genetics at four sites
To explore the genetic influence on DNA methylation at the 86
maternal BMI-associated cord blood methylation sites, we per-
formed a look-up in an online catalogue of methylation quanti-
tative trait loci (meQTL) that were previously identified using
ALSPAC data (35). We identified 821 meQTLs where genetic var-
iation was associated with cord blood DNA methylation at 27/86
Table 4. Characteristics of each cohort included in the meta-analysis of the effect of maternal pre-pregnancy BMI on offspring DNA
methylation at adolescence
Cohort N Mean maternal BMI (SD) Mean maternal age (SD) Mean adolescent age (SD) Ethnicity
BAMSE 221 23.2 (3.4) 31.2 (4.3) 16.6 (0.3) European
IOW F1 279 24.4 (4.0) 27.3 (5.2) 18.0 (0.0) European
PIAMA 583 22.6 (3.1) 30.9 (3.7) 16.3 (0.2) European
RAINE 734 22.4 (4.4) 29.1 (5.8) 17.3 (0.6) European
Meta-analysis 1817
Figure 4. Comparison of estimates of the effect of maternal BMI on offspring DNA methylation at birth and at adolescence. Of the 86 sites where maternal BMI at the
start of pregnancy was associated with newborn blood methylation, 72 had the same direction of association in the analysis of adolescents. Plotted here are the 22/86
methylation sites with a P-value<0.05 in the analysis of adolescents, ordered by effect size in newborns.
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sites with P< 1107. Of these 821 meQTLs, 68 were within 1 Mb
of the methylation site (cis) and 753 were outside of this win-
dow (trans).
If an meQTL is also associated with maternal BMI, this could
suggest that the association between maternal BMI and new-
born methylation is confounded by shared genetics. Of the 821
identified meQTLs, data for 225 were available in the results of
the largest adult BMI GWAS meta-analysis to date, conducted
by the GIANT consortium (36). Of these, 17/225 were nominally
associated (P< 0.05) with BMI in GIANT. These 17 meQTLs were
associated with cis methylation at four CpGs: 11 with
cg03258665 (EPHA2), four with cg00285394 (SQLE), one with
cg03719642 (UCKL1) and one with cg18268562 (FOXR1).
Therefore, there is some evidence that associations between
maternal BMI and methylation at these four sites are con-
founded by shared genetics. For most of the meQTLs, the associ-
ations SNP-BMI and SNP-methylation were in opposite
directions. Thus, the same effect allele was associated with
higher BMI (effect estimates ranging 0.007 to 0.015) and lower
methylation (effect estimates ranging 0.523 to 0.235). Only in
the rs8567-cg03719642 association was the effect allele associ-
ated with lower BMI (effect estimate: 0.012) and higher meth-
ylation (effect estimate: 0.287).
Using a combination of evidence, we identified eight
sites where maternal BMI may have a causal
intrauterine effect on newborn blood methylation
As described above, by employing a negative control design,
we found nine sites where the estimated effect of maternal
BMI was stronger than that of paternal BMI. One of these sites
(cg18268562 at FOXR1) is an meQTL that was nominally associ-
ated with BMI in GIANT. Therefore, we find strongest support
for a causal intrauterine effect of maternal BMI at the start of
pregnancy on newborn blood methylation at just eight sites
(Table 5). At the remaining 78 of our top 86 sites, the apparent
associations between maternal BMI and newborn blood meth-
ylation might be more appropriately explained by shared
mother-offspring genetic and postnatal environmental factors.
These findings are summarised in Supplementary Material,
Table S14.
Discussion
We found that maternal BMI at the start of pregnancy is associ-
ated with small variation in newborn blood DNA methylation at
86 sites throughout the genome, after adjusting for cell propor-
tions. At around a quarter of these 86 sites, we found nominal
associations between maternal pre-pregnancy BMI and DNA
methylation in an independent cohort of adolescents, some-
times with remarkably consistent effect sizes to those found in
neonates. However, when we employed two causal inference
strategies, we found supporting evidence for a causal intrauter-
ine effect at only eight sites. Taken together, our results suggest
that the effects of maternal pre-pregnancy adiposity on neona-
tal blood DNA methylation are primarily related to variations in
the cellular distributions in cord blood, as well as shared envi-
ronment and genetic variation. Although there may be a causal
intrauterine effect at some sites, the biological significance of
such small effects is unclear.
Figure 5. Comparison of estimates of the effect of maternal and paternal BMI on newborn DNA methylation. Of the 86 sites where maternal BMI at the start of preg-
nancy was associated with newborn blood methylation, we found 20 sites (plotted here) where the estimated effect of maternal BMI, adjusted for paternal BMI, had a
P-value<0.05 and was in the same direction and greater than the estimated effect of paternal BMI, adjusted for maternal BMI. Sites are ordered by P-value in the full
maternal BMI meta-analysis.
Table 5. A summary of the 8 sites where there is strongest evidence for a causal intrauterine effect of maternal BMI on newborn blood DNA
methylation
CHR CPG Coordinate Nearest
genE
Illumina annotated
gene
Relation to
CPG island
Relation
to gene
ba at
birth
P at birth ba at
adolescence
P at
adolescence
17 cg09243648 45944464 SP6 6.0E-04 1.1E-09 2.0E-05 8.9E-01
20 cg13403462 32256071 NECAB3 ACTL10;NECAB3 South shore Body; 1st Exon 1.4E-03 2.4E-09 1.6E-03 4.1E-03
1 cg20594982 976707 AGRN AGRN Island Body 1.0E-03 5.2E-09 1.2E-03 1.5E-03
8 cg18144647 41113257 SFRP1 5.2E-04 1.1E-08 5.6E-04 9.1E-03
1 cg14528056 155194782 GBAP1 GBAP1 North shelf Body 5.1E-04 1.5E-08 2.9E-04 1.7E-01
6 cg01963618 1102332 LINC01622 LOC285768 TSS1500 3.5E-04 2.4E-08 1.8E-04 1.9E-01
2 cg05113927 27531244 UCN UCN Island TSS200 6.1E-04 3.9E-08 5.9E-04 9.4E-03
16 cg05635274 2866901 PRSS21 PRSS21 North shore TSS1500 4.8E-04 5.0E-08 3.7E-04 2.1E-01
aDifference in offspring DNA methylation beta value per 1 kg/m2 increase in maternal pre-pregnancy BMI.
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Our findings are in contrast to some previous studies that
have reported strong associations between maternal BMI/
adiposity and DNA methylation in neonates (21,24–26,37,38).
However, in these smaller studies there has been a lack of con-
sistency in terms of the specific loci identified. Although we
replicated, at look-up level of significance, an inverse associa-
tion between maternal BMI and newborn blood methylation at
cg01422136 (ZCCHC10) that was reported in a study of African
American and Haitian mother-child pairs from the Boston Birth
Cohort (24), this association was not epigenome-wide signifi-
cant in our study (P¼ 0.0016). We did not replicate specific asso-
ciations reported in other previous studies of maternal BMI and
newborn blood methylation, including some that were reported
in individual studies from the PACE consortium (21,25,26,37,38).
This lack of consistency highlights the potential presence of
false positive findings in small EWAS studies and the impor-
tance of meta-analysis for improving power and reproducibility.
The 86 Bonferroni-significant sites were robust across
cohorts and after adjustment for cell proportions, so they are
unlikely to have arisen due to chance, study-specific biases or
technical aspects of the array, which should be independent of
our exposure. However, effect sizes were very small; all were
less than a 0.15% change in methylation per one-unit increase
in maternal BMI. The biological significance of such small
effects is unclear and could not be further explored in this study
due to lack of genome-wide data on downstream gene and pro-
tein expression. One reason we may not have observed larger
effect sizes is that the studied cohorts consisted mostly of
women whose weight fell within the WHO BMI category of nor-
mal weight. Perhaps the largest effects only exist at the extrem-
ities of the BMI distribution, as is the case with some other
maternal BMI-associated offspring phenotypes, including off-
spring BMI (6). However, we also found relatively small effects
in our binary exposure model comparing methylation in off-
spring of women who were overweight or obese to methylation
in offspring of women who were normal weight at the start of
pregnancy.
Without integration with gene expression data, it is impossi-
ble for us to truly infer (either way) whether maternal BMI-
associated variation in methylation at our 86 sites is function-
ally important. The 77 mapped genes were not enriched for any
GO term or KEGG pathway, which could suggest that there is lit-
tle or no significant biological effect. However, this analysis was
likely underpowered and it is worth noting that, individually,
some of the 77 genes that map to our 86 sites have functions
that could potentially link maternal adiposity to offspring
health outcomes, either through shared genetic factors or an
epigenetic effect on gene regulation. These may be useful candi-
dates for future studies that are better placed to explore the bio-
logical significance of the methylation sites we have identified.
For example, GWAS studies have identified that variants at
some of our differentially methylated loci are associated with
adiposity-related traits: total energy total energy expenditure
[CDHR3 (39)], energy intake [PTPRN2 (39)], lipoprotein-a levels
[DSCAML1 (40)], adiponectin levels [CREG2 (41)], and type 2 dia-
betes [ANK1, RBMS1 (42–44)]. In studies of DNA methylation,
greater whole blood methylation at cg17782974 (TRIM8) was
associated with higher BMI in elderly participants in the
Lothian Birth Cohort study (45) and higher maternal BMI in our
study. Another 450k study found that several sites at PTPRN2
were hypermethylated in subcutaneous adipose tissue of
women before gastric-bypass compared to the same women
after gastric-bypass and associated weight-loss (46), whereas
we found that higher maternal BMI at the start of pregnancy
was associated with hypomethylation at PTPRN2 in newborn
blood. We also found that higher maternal BMI at the start of
pregnancy was associated with lower newborn methylation at a
site (cg03221837) near IRX3. More copies of the risk allele at the
obesity-associated SNP FTO is associated with higher blood
expression of IRX3 in humans, and IRX3-deficient mice have
been shown to have a 25-30% reduction in body weight (47).
However, it is important to note that although IRX3 was the
nearest gene to the maternal BMI-associated methylation site
in our study, the site was actually 299,591 bp downstream
fromthe gene. Finally, we were particularly interested to find
two sites (cg12009398, cg05086444) on the gene body of VIPR2
where greater maternal BMI was associated with lower meth-
ylation. The associations were consistent in adolescents, with
P-values<0.008, although we did not find any evidence that
the associations were causal. VIPR2 encodes vasoactive intesti-
nal peptide receptor 2 (VIPR2), which functions as a neuro-
transmitter and as a neuroendocrine hormone. A GWA
analysis in 1,000 participants found that the vasoactive intesti-
nal peptide (VIP) pathway was strongly associated with fat
mass and with BMI, suggesting that the VIP pathway may play
an important role in the development of obesity (48). In a study
using the 450k array, lower VIPR2 methylation was found in
the saliva of children with attention deficit hyperactivity disor-
der (ADHD), relative to controls (49), albeit at different sites
than those identified in the present study. Given previously
identified associations between maternal BMI and offspring
ADHD (50–53), further work is warranted to explore the extent
to which VIPR2 gene function (driven either by genetic varia-
tion or regulation by methylation) might explain associations
between maternal adiposity and neurodevelopment of the
offspring.
Of the 86 sites where maternal BMI was associated with
methylation in the blood of newborns, 72 showed the same
direction of association in the blood of an independent smaller
sample of adolescents. At some sites, effect estimates were
remarkably consistent between the two age groups. Of particu-
lar note, six of the top 10 sites with the largest effect size in the
cell-adjusted newborn analysis also had the largest effect size
amongst adolescents. This consistency from birth to adoles-
cence could be explained as either i) an intrauterine influence of
maternal pre-pregnancy BMI on variation in offspring DNA
methylation that persists to adolescence, ii) confounding by
shared familial genetic and/or environmental influences on
maternal BMI and offspring methylation that remain stable
over time, or iii) the possibility that both maternal pre-/early-
pregnancy and the adolescent’s own BMI have independent
effects on the child’s methylation. We did not adjust for adoles-
cent’s BMI because that may introduce a collider that would
bias the association between shared familial factors and mater-
nal BMI away from the null.
We were interested in whether the 86 maternal BMI-
associated sites represented a causal intrauterine effect of
maternal adiposity on offspring methylation, or if associations
were better explained by confounding by shared environment
or genetics. By employing a negative control design, we found
nine sites where the estimated effect of maternal BMI was
larger than that of paternal BMI, after mutual adjustment.
Maternal and paternal BMI were not strongly correlated in any
of the cohorts that took part in this analysis (Spearman’s R
ranging 0.13 to 0.25), so collinearity in the mutually adjusted
models is unlikely to bias interpretation of results. This is sup-
ported by the observation that standard errors did not increase
substantially between the unadjusted and adjusted models. At
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one of the nine sites (cg18269562 mapping to FOXR1), cord blood
methylation has previously been strongly associated
(P< 1107) with common genetic variants (35). This meQTL
was also nominally associated (P< 0.05) with BMI according to
the GIANT consortium adult BMI GWAS meta-analysis (36,54).
We considered that the association between maternal BMI and
newborn methylation at this site was likely driven by a shared
genetic effect. Therefore, we could be more confident of a causal
intrauterine effect of maternal adiposity on methylation of
blood DNA in newborns at only 8/86 sites. At the remaining 78/
86 sites, shared genetic and/or prenatal environmental factors,
which would be expected to be the same whether the exposure
were maternal or paternal BMI, may have larger influences on
newborn blood methylation than maternal BMI at the start of
pregnancy.
Our findings are in line with studies reporting that a large
proportion of variation in DNA methylation is explained by
genetics. One study estimated that at around 50% of CpG sites
on the Illumina 450k array methylation has a substantial
genetic component (55). Another study of DNA methylation
using the same platform in 237 neonates found that, of 1,423
genomic regions that were highly variable across individuals,
25% were best explained by genotype alone and 75% by an inter-
action of genotype with different in utero environmental factors
(including maternal BMI) (56). These studies, along with our
own, highlight complex relationships between genetic inheri-
tance, intrauterine environmental exposures and offspring epi-
genetics. In light of this, we recommend that where the
exposure is genetically heritable, extra care should be taken to
avoid over-interpreting EWAS results as representing causal
environmental effects (57). Causal analysis techniques, such as
the negative control and meQTL analyses conducted in this
study, will be useful in this regard.
Regardless of whether maternal BMI has a biologically signif-
icant, causal effect on newborn blood DNA methylation, the
robust, and seemingly persistent, associations we identified in
our study suggests that, as has been shown for maternal smok-
ing (58), blood DNA methylation could be a useful indicator of
maternal BMI during pregnancy. Such an indicator would be
useful in studies where maternal BMI data are missing.
Likewise, newborn blood methylation at maternal BMI-
associated sites might also be predictive of offspring outcomes,
capturing both genetic and environmental influences of mater-
nal adiposity.
Although our findings suggest no strong effect of maternal
pre-pregnancy adiposity (as measured by BMI) on offspring
methylation in blood, this does not preclude the possibility that
there is an effect of maternal adiposity measured in different
ways and/or on offspring methylation in different tissues. It will
be interesting to explore in further work how maternal
adiposity-associated exposures during pregnancy, such as gesta-
tional weight gain, maternal hypertension and hyperglycemia,
influence offspring DNA methylation. Such pregnancy expo-
sures may be more likely to have a pronounced intrauterine
effect on offspring methylation and/or developmental program-
ming of health outcomes than maternal adiposity at the start of
pregnancy. Although previous studies in ALSPAC (21) and MoBa
(59) did not identify any sites where gestational weight gain was
associated with cord blood methylation, the question should be
revisited in a consortium context. Further exploration is also
warranted to assess the degree to which methylation in blood
correlates with that in other tissues. DNA methylation shows
strong tissue-specificity, for example, one study found that BMI
was associated with DNA methylation in adipose tissue, but not
in peripheral blood leukocytes (60). Conversely, a large EWAS
found that BMI was associated with methylation at HIF3A in
both blood and adipose tissues (61). The causal effect of mater-
nal BMI on newborn methylation may be stronger in tissues
other than blood. However, we note that in the context of this
study, offspring blood might be considered a mechanistically
relevant tissue: blood cellular heterogeneity and leukocyte
methylation are strongly associated with inflammation, which
is considered chronic amongst those with obesity.
There are several strengths to our study, including the large
sample size comprised of established cohorts, the use of robust
statistical methods, the comprehensive analysis of results and
the application of causal inference techniques. Potential limita-
tions include: i) adiposity is a complex trait that is only crudely
and indirectly measured by BMI, therefore an investigation of
more specific measures of adiposity might yield different
results, ii) cohorts collected data on BMI in different ways
(measured/self-reported) at different times (pre-pregnancy/
early pregnancy). However, measured and self-reported BMI
before and during early pregnancy are strongly correlated (62),
so we do not believe this will bias our results substantially. iii)
The analysis was completed before the widespread availability
of any cord blood reference panels for estimations of cell
counts, so all cohorts used an adult whole blood reference
panel, which may introduce measurement error in cell count
estimates (28). However, in ALSPAC, one of the largest partici-
pating cohorts, we found that adjusting for cell counts gener-
ated using any one of three recently released cord blood
reference panels produced results consistent with those pro-
duced using the adult whole blood reference. Nevertheless, we
consider that there is likely to be at least some degree of resid-
ual influence of cell heterogeneity in our results. iv) We had
very limited data with repeat measures in the same individuals
at birth and adolescence, so we did not explore change in meth-
ylation over time in a longitudinal model. v) Cohorts used differ-
ent methods to normalise data. However, a previous PACE
analysis (63) found that results obtained using raw betas were
similar to those obtained using normalized betas generated
with various methods, which indicates that this did not impact
the inferences drawn from the meta-analysis, and at any rate,
bias would tend to limit power rather than introduce spurious
associations. vi) Although we have presented two lines of evi-
dence (consistent maternal and paternal estimates and the
presence of meQTLs) that provide support for a genetic compo-
nent in explaining associations between maternal BMI and
newborn blood methylation at some sites, we were unable to
formally quantify the relative contribution of genetics and the
intrauterine environment. Techniques that attempt to do so,
such as M-GCTA (64), require genetic and methylation data on
larger sample sizes than were available in any individual cohort.
vii) The Illumina 450k array only covers 1.7% of CpG sites on the
human genome, and most of these are located in promoter
regions. We found robust associations between maternal BMI
and newborn DNA methylation despite this low coverage and
bias. We therefore encourage more studies on this topic using
more advanced EWAS platforms (such as the Illumina EPIC
array). viii) Finally, it is possible that epigenetic markers other
than DNA methylation in cord blood may be more closely asso-
ciated with maternal BMI at the start of pregnancy, but this was
not explored in this study.
In conclusion, in this well-powered study, we observed
robust associations between maternal pre/early-pregnancy BMI
and DNA methylation at 86 sites in the blood of newborns,
some of which were reproduced in adolescents. However, effect
4079Human Molecular Genetics, 2017, Vol. 26, No. 20 |
sizes were very small, there was no evidence of biological func-
tional enrichment, and causal inference strategies provided
support for causal effects at just 8/86 sites. This study highlights
that although some small studies report strong associations
between prenatal exposures and epigenetics, large-scale collab-
orative efforts are necessary to identify robust associations, and
causal inference strategies are needed to assess whether such
associations are likely to be explained by a direct intrauterine
effect or more likely due to genetic or shared environmental
factors.
Materials and Methods
Figure 1 gives an outline of the design of this study.
Participating cohorts
A total of 23 independent cohorts participated. Detailed meth-
ods for each cohort are provided (Supplementary Methods) and
summarised in Supplementary Material, Table S1.
Nineteen cohorts participated in the meta-analysis of mater-
nal BMI at the start of pregnancy and newborn blood DNA
methylation: The Avon Longitudinal Study of Parents and
Children (ALSPAC) (65–67); two independent datasets from the
Californian Birth Cohort (CBC_Hispanics and CBC_Caucasians)
(68); Center for the Health Assessment of Mothers and Children
of Salinas (CHAMACOS); Early Autism Risk Longitudinal
Investigation (EARLI) (69); the Genome-Wide Population-based
Association Study of Extremely Overweight Young Adults
(GOYA), which is a sample from the Danish National Birth
Cohort (70,71); Groningen Expert Center for Kids with Obesity
(GECKO); Generation R (GENR) (72); Genetics of Glycemic
Regulation in Gestation and Growth (GEN3G) (73); the Isle of
Wight Birth Cohort third generation (IOW F2) (74); two cohorts
from the FP7 project Mechanisms of the Development of Allergy
(MEDALL), INfancia y Medio Ambiente (INMA) (75) and a study
on the pre- and early postnatal; determinants of child health
and development (EDEN) (76), were pooled and analysed as a
single cohort referred to as MEDALL; three independent data-
sets from the Norwegian Mother and Child Cohort Study
(MOBA1, MOBA2, MOBA3) (77,78); the Norway Facial Clefts Study
(NFCS), the Newborn Epigenetic Study (NEST) (79,80); the New
Hampshire Birth Cohort Study (NHBCS); the Rhode Island Child
Health Study (RICHS) (81) and Project Viva (Viva).
An additional four independent cohorts participated in the
meta-analysis of maternal BMI at the start of pregnancy and off-
spring whole blood DNA methylation at adolescence (ages 15-18):
the Children Allergy Milieu Stockholm Epidemiology cohort
(BAMSE) (82), IOW birth cohort second generation (IOW F1), the
Prevention and Incidence of Asthma and Mite Allergy birth
cohort (PIAMA), the Western Australia Pregnancy Cohort (RAINE).
All cohorts acquired ethics approval and informed consent
from participants prior to data collection through local ethics
committees. Full details are provided in the Supplementary
Methods.
Maternal BMI at the start of pregnancy
In each cohort, maternal BMI [weight (kg)/height (m2)] was cal-
culated from either self-reported or measured height and
weight, either before pregnancy or early in the first trimester
(Supplementary Material, Table S1). Cohorts were asked to dou-
ble check values5 standard deviations from the mean to
ensure that they were not data entry errors. Primarily, we were
interested in the effects of maternal BMI as a continuous varia-
ble, but also investigated World Health Organization categories
of maternal overweight or obesity (25.0 kg/m2), and under-
weight (<18.5 kg/m2), compared to a normal weight reference
group (18.5–24.9 kg/m2).
Covariates
All cohorts ran models adjusted for maternal age (years), mater-
nal social class (variable defined by each individual cohort),
maternal smoking status (the preferred categorization was into
three groups: no smoking in pregnancy, stopped smoking in
early pregnancy, smoking throughout pregnancy, but a binary
categorization of any versus no smoking was also acceptable)
and parity (the preferred categorization was into two groups: no
previous children, one or more previous children). We did not
adjust for or stratify by sex of the child because sex cannot be a
true confounder of any association between maternal pre-
pregnancy BMI and offspring methylation; although it has a
large influence on methylation, it cannot feasibly alter pre-
pregnancy BMI. Furthermore, because the intrauterine hormo-
nal environment is likely to be different for males and females,
and could also be influenced by maternal BMI, we would risk
introducing collider bias by adjusting for sex, which would be
strongly correlated with sex-associated hormonal environment
on the causal pathway between maternal BMI and methylation.
Each cohort also adjusted for technical covariates using
methods suitable for that cohort (Supplementary Material,
Table S1). Certain cohorts also included additional covariates to
correct for study design/sampling factors where needed
(Supplementary Material, Table S1). For GOYA, which is a case-
control study where case mothers have a BMI> 32 kg/m2 and
control mothers have a BMI anywhere within the normal distri-
bution, we restricted the continuous maternal BMI models to a
randomly selected sub-group with a normal BMI distribution to
avoid confounding by substructure. Binary comparison models
were run using the whole GOYA cohort with no additional
adjustment for substructure.
We hypothesised that BMI might influence newborn blood
cellular composition, so each cohort additionally adjusted for cell
proportions by including the estimated variables as covariates.
All cohorts independently estimated cell counts using the
estimateCellCounts function in the minfi R package, which is based
on the method developed by Houseman (83,84). The cohort-
specific analyses, as well as the meta-analyses, were completed
before a cord blood reference set was widely available, so cohorts
used an adult whole blood reference to estimate cell counts (85).
This estimated the proportion of B-cells, CD8þT-cells, CD4þT-
cells, granulocytes, NK-cells and monocytes in each sample.
NHBCS, RICHS and Project Viva included five estimated cell types
(omitting granulocytes) and all other cohorts included six. When
cord blood references became available (28–30), a sensitivity
analysis was run in ALSPAC adjusting for cell proportions esti-
mated using these reference sets. One of these reference sets
includes nucleated red blood cells, which can contribute greatly
to cord blood DNA methylation profiles (28).
Methylation measurements and quality control
Each cohort conducted its own laboratory measurements. DNA
from newborn or adolescent blood samples underwent bisulfite
conversion using the EZ-96 DNA Methylation kit (Zymo
Research Corporation, Irvine, USA). For all cohorts, DNA
methylation was measured using the Illumina InfiniumVR
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HumanMethylation450 BeadChip assay (86,87) at Illumina or in
cohort-specific laboratories. Each cohort also conducted its own
quality control and normalisation of methylation data, as
detailed in the Supplementary Methods (Supplementary
Material, Fig. S2) and summarised in Supplementary Material,
Table S1. In all analyses, cohorts used normalised, untrans-
formed beta-values, which are on a scale of 0 (completely
unmethylated) to 1 (completely methylated).
Cohort-specific statistical analyses
Each cohort performed independent epigenome-wide associa-
tion studies (EWAS) according to a common, pre-specified anal-
ysis plan. Models were run using M-type multiple robust linear
regression [rlm in the MASS R package (88)] in an attempt to
control for potential heteroscedasticity and/or influential out-
liers in the methylation data. In the primary analysis, continu-
ous maternal BMI at the start of pregnancy was modelled as the
exposure and offspring individual CpG-level methylation
(untransformed beta-values) was modelled as the outcome,
with adjustment for covariates and estimated cell counts. In
secondary models, we modelled the exposure as binary varia-
bles comparing WHO BMI categories to a normal weight
reference group. We also explored the impact of cellular compo-
sition by comparing models run with and without adjustment
for estimated cell counts.
Meta-analysis
Cohorts uploaded their EWAS results files to a server at the
University of Bristol, where we performed fixed-effects meta-
analysis weighted by the inverse of the variance with METAL
(89). A shadow meta-analyses was also conducted independ-
ently by authors at the Erasmus University in Rotterdam to min-
imise the likelihood of human error. All downstream analyses
were conducted using R version 2.5.1 or later (90). We excluded
control probes (N¼ 65), and probes mapped to the X (N¼ 11,232)
or Y (N¼ 416) chromosomes. This left a total of 473,864 CpGs
measured in at least one cohort (218,350 [46%] of these were
measured in all 19 cohorts, 393,986 [83%] were measured in at
least 18 cohorts). Multiple testing was accounted for using
the Bonferroni method. CpGs with a Bonferroni-corrected
P-value<0.05, i.e. P< 1.06107, in both the cell proportion-
unadjusted and cell proportion-adjusted models were taken
forward for further analysis. To assess heterogeneity, we gener-
ated forest plots, and ran random effects models and “leave-
one-out” analyses using the metafor R package (91). We
compared our Bonferroni-significant probes to a list of poten-
tially problematic probes published by Naeem et al. We did not
remove these probes as this would risk removing potentially
interesting effects. However, we tested whether these probes
contained large numbers of outlying values by performing dip
tests (92) for multimodality using the diptest package (34),
where a P> 0.05 suggests the distribution is unimodal.
Kolmogorov-Smirnov tests were used to compare the distribu-
tion of P-values to that expected by chance and were conducted
using the core R function ks.test().
Enrichment and functional analysis
Sites were annotated using the IlluminaHumanMethylation450k.db
R package (93), with enhanced annotation for nearest genes within
10 Mb of each site, as previously described (63). These annotations
were then updated using the R package mygene (94). Gene Ontology
(GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrich-
ment analyses were performed using the missMethyl R package
(95). This takes into account the differing number of sites associated
with each gene on the 450k array. P-values for enrichment were
adjusted for multiple testing using the FDR method.
Reproduction of maternal BMI-related differential DNA
methylation in adolescence
Four cohorts independently performed robust linear regression
to assess the association between maternal BMI at the start of
pregnancy and (mixed gender) adolescent whole blood DNA
methylation. Each of these cohorts ran models adjusted for
maternal smoking, maternal age, socioeconomic status, parity
during the index pregnancy and estimated cell counts. Results
were uploaded to the server at the University of Bristol where
they were summarised using fixed effects meta-analysis in the
metafor package (91). A look-up of maternal BMI-related sites
identified in the newborn meta-analysis (n¼ 86 with
P< 1.06107 in the cell-adjusted and cell-unadjusted models)
was performed and FDR correction applied to account for multi-
ple testing. These “reproduction” cohorts were completely inde-
pendent from the original “discovery” cohorts.
Negative control design
In an attempt to examine a potential causal effect of maternal
BMI on newborn blood methylation at identified sites, we used a
negative control design (7). In this analysis, estimates for associa-
tions between maternal BMI and offspring DNA methylation
were compared to the equivalent estimates for paternal BMI (the
negative control), with adjustment for the other parent’s BMI.
Seven cohorts (ALSPAC, CHAMACOS, Generation R, GOYA,
MEDALL [INMA and EDEN pooled], NHBCS, RICHS) with the nec-
essary data independently performed robust linear regression
to assess the association between paternal BMI (kg/m2) and
newborn blood DNA methylation at sites identified as associ-
ated with maternal BMI. Each cohort ran models adjusted for
maternal smoking, age, socioeconomic status, parity and esti-
mated cell counts. We also explored the independent effect of
maternal and paternal BMI in mutually adjusted models.
Results for each of the seven cohorts were uploaded to the
server at the University of Bristol where they were summarised
using fixed effects inverse-variance weighted meta-analysis
and compared to meta-analysed results of the maternal effect
in these seven cohorts. The criteria for evidence of an intrauter-
ine effect were, in the mutually adjusted models, 1) maternal
BMI and paternal BMI show the same direction of association
with offspring methylation (i.e. paternal BMI is not having an
independent effect in the opposite direction to the effect of
maternal BMI), 2) the magnitude of association with offspring
methylation is larger for maternal BMI than for paternal BMI, 3)
there is evidence of heterogeneity (an I2 value>40) in a meta-
analysis of the maternal and paternal mutually-adjusted esti-
mates. We also calculated heterogeneity P-values between the
mutually adjusted maternal and paternal BMI estimates using
the metafor R package (91).
Identification of methylation quantitative trait loci
(meQTLs)
We performed a look-up of maternal BMI-associated methyla-
tion sites in an online catalogue of both cis- (within 100 kb) and
trans- methylation quantitative trait loci (meQTLs) identified in
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an ALSPAC study (http://mqtldb.org/; date last accessed July 29,
2017) (35). The meQTLs were identified in cord blood of 771 chil-
dren at birth using 395,625 methylation probes and 8,074,398
SNP loci after adjustment for sex, the top ten ancestry principal
components, bisulfite conversion batch and estimated cell
counts. A P-value threshold of 1107 was used to define
meQTLs (35). We compared the list of meQTLs to results of an
adult BMI GWAS published by the GIANT consortium (36,54).
meQTLs were considered nominally associated with BMI if the
GWAS P-value was<0.05. FDR correction for multiple testing
was also performed.
Availability of data and materials
Data supporting the results reported in this article can be found
in the Supplemental Material (Supplementary Tables). We are
unable to make individual level data available due to concerns
regarding compromising individual privacy, however full meta-
analysis results datasets generated in this study are available
from the corresponding author (gemma.sharp@bristol.ac.uk) on
request.
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